Cargando…

The Biomarkers for Acute Myocardial Infarction and Heart Failure

The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi-Ying, Zhang, Fen, Zhang, Chi, Zheng, Liang-Rong, Yang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988690/
https://www.ncbi.nlm.nih.gov/pubmed/32016113
http://dx.doi.org/10.1155/2020/2018035
_version_ 1783492300334170112
author Wang, Xi-Ying
Zhang, Fen
Zhang, Chi
Zheng, Liang-Rong
Yang, Jian
author_facet Wang, Xi-Ying
Zhang, Fen
Zhang, Chi
Zheng, Liang-Rong
Yang, Jian
author_sort Wang, Xi-Ying
collection PubMed
description The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the management of patients with suspected cardiovascular diseases. There is a broad consensus that cardiac troponin and natriuretic peptides are the preferred biomarkers in clinical practice for the diagnosis of the acute coronary syndrome and heart failure, respectively, while the roles and possible clinical applications of several other potential biomarkers are still under study. This review mainly focuses on the recent studies of the roles and clinical applications of troponin and natriuretic peptides, which seem to be the best-validated markers in distinguishing and predicting the future cardiac events of patients with suspected cardiovascular diseases. Additionally, the review briefly discusses some of the large number of potential markers that may play a more prominent role in the future.
format Online
Article
Text
id pubmed-6988690
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69886902020-02-03 The Biomarkers for Acute Myocardial Infarction and Heart Failure Wang, Xi-Ying Zhang, Fen Zhang, Chi Zheng, Liang-Rong Yang, Jian Biomed Res Int Review Article The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the management of patients with suspected cardiovascular diseases. There is a broad consensus that cardiac troponin and natriuretic peptides are the preferred biomarkers in clinical practice for the diagnosis of the acute coronary syndrome and heart failure, respectively, while the roles and possible clinical applications of several other potential biomarkers are still under study. This review mainly focuses on the recent studies of the roles and clinical applications of troponin and natriuretic peptides, which seem to be the best-validated markers in distinguishing and predicting the future cardiac events of patients with suspected cardiovascular diseases. Additionally, the review briefly discusses some of the large number of potential markers that may play a more prominent role in the future. Hindawi 2020-01-16 /pmc/articles/PMC6988690/ /pubmed/32016113 http://dx.doi.org/10.1155/2020/2018035 Text en Copyright © 2020 Xi-Ying Wang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wang, Xi-Ying
Zhang, Fen
Zhang, Chi
Zheng, Liang-Rong
Yang, Jian
The Biomarkers for Acute Myocardial Infarction and Heart Failure
title The Biomarkers for Acute Myocardial Infarction and Heart Failure
title_full The Biomarkers for Acute Myocardial Infarction and Heart Failure
title_fullStr The Biomarkers for Acute Myocardial Infarction and Heart Failure
title_full_unstemmed The Biomarkers for Acute Myocardial Infarction and Heart Failure
title_short The Biomarkers for Acute Myocardial Infarction and Heart Failure
title_sort biomarkers for acute myocardial infarction and heart failure
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988690/
https://www.ncbi.nlm.nih.gov/pubmed/32016113
http://dx.doi.org/10.1155/2020/2018035
work_keys_str_mv AT wangxiying thebiomarkersforacutemyocardialinfarctionandheartfailure
AT zhangfen thebiomarkersforacutemyocardialinfarctionandheartfailure
AT zhangchi thebiomarkersforacutemyocardialinfarctionandheartfailure
AT zhengliangrong thebiomarkersforacutemyocardialinfarctionandheartfailure
AT yangjian thebiomarkersforacutemyocardialinfarctionandheartfailure
AT wangxiying biomarkersforacutemyocardialinfarctionandheartfailure
AT zhangfen biomarkersforacutemyocardialinfarctionandheartfailure
AT zhangchi biomarkersforacutemyocardialinfarctionandheartfailure
AT zhengliangrong biomarkersforacutemyocardialinfarctionandheartfailure
AT yangjian biomarkersforacutemyocardialinfarctionandheartfailure